Nine Hospitals Procure 50% COVID Vaccine, Raise Concerns Of Uneven Distribution

After the Centre relaxed vaccine policy in May, nine corporate hospitals purchased 60.57 lakh vaccine doses out of 1.20 crore doses meant for the private players while the rest were bought by 300-odd hospitals mostly in Tier 1 and 2 cities of the country.

India   |   5 Jun 2021 7:41 AM GMT
Writer : Sanal M Sudevan | Editor : Palak Agrawal | Creatives : Sanal M Sudevan
Nine Hospitals Procure 50% COVID Vaccine, Raise Concerns Of Uneven Distribution

Picture credit: ANI

In what could be considered as an inequitable distribution of COVID vaccines, as many as nine private hospitals accumulated 50 per cent of stock that was meant for the private sector in the month of May, reported The Indian Express.

After the Central government relaxed the vaccine policy, these nine corporate private hospitals cumulatively purchased 60.57 lakh doses out of the total 1.20 crore doses of vaccines procured by the private hospitals, and the rest vaccines were bought by the 300-odd hospitals from the other regions, mostly in Tier 1 and 2 cities of the country.

According to the new policy, the Centre had given permission to state government and private players to acquire 50 per cent vaccine doses of the total output from the market on May 1. On the other hand, the Centre had confined itself to procuring another 50 per cent of vaccine output for distributing the jab to vaccinate people above the 45+ age group.

According to the report, the nine hospitals include Apollo Hospitals which procured 16.14 lakh of doses, Max Healthcare (12.17 lakh), HN Reliance (9.89 lakh), Medica Hospitals (6.26 lakh), Fortis Hospitals (4.48 lakh), Godrej Memorial (3.35 lakh), Manipal Health (3.24 lakh), Techno India (2.26 lakh), and Narayana Hrudayalaya (2.02 lakh).

Out of the 7.94 crore production of vaccine doses, the private hospital procured 1.20 crore of doses, which stood at 15.6 per cent of the total production. They were able to administer only 22 lakh doses or 18 per cent of the doses received during the month.

Meanwhile, the states procured 2.66 lakh crore doses or 18 per cent of the production during the month, the Centre bought 50.3 per cent of doses or 4.03 crore in May.

Serum Institute of India and Bharat Biotech, the two major vaccine producers in India, sold the vaccines to private hospitals at ₹600 per dose and ₹1,200 per doses, respectively. The hospitals are charging consumers in the range of ₹850-1000 for Covishield and ₹1,250 for Covaxin.

Also Read: US Colleges Ask Students Who Took Covaxin, Sputnik V To Revaccinate

Suggest a correction

    Help Us Correct

    To err is human, to help correct is humane
    Identified a factual or typographical error in this story? Kindly use this form to alert our editors
  • *
  • *
  • *
  • Form Submitted Successfully
    Error in submitting form. Try again later

Contributors

Sanal M Sudevan

Sanal M Sudevan

Digital Editor

Keen to explore new things and learn something new every day in the field of jounalism.

Palak Agrawal

Palak Agrawal

Digital Editor

Palak a journalism graduate believes in simplifying the complicated and writing about the extraordinary lives of ordinary people. She calls herself a " hodophile" or in layman words- a person who loves to travel.

Sanal M Sudevan

Sanal M Sudevan

Digital Editor

Keen to explore new things and learn something new every day in the field of jounalism.

Next Story